Ambea Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Ambea has been growing earnings at an average annual rate of 14.1%, while the Healthcare industry saw earnings growing at 20% annually. Revenues have been growing at an average rate of 6.6% per year. Ambea's return on equity is 11.6%, and it has net margins of 4%.
Belangrijke informatie
14.1%
Groei van de winst
12.8%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.1% |
| Inkomstengroei | 6.6% |
| Rendement op eigen vermogen | 11.6% |
| Nettomarge | 4.0% |
| Volgende winstupdate | 06 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
We Think Ambea's (STO:AMBEA) Profit Is Only A Baseline For What They Can Achieve
Aug 23
Most Shareholders Will Probably Find That The CEO Compensation For Ambea AB (publ) (STO:AMBEA) Is Reasonable
May 09Earnings Beat: Ambea AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 08Ambea (STO:AMBEA) Is Increasing Its Dividend To SEK1.50
Apr 14We Think Ambea's (STO:AMBEA) Profit Is Only A Baseline For What They Can Achieve
Feb 15Is It Time To Consider Buying Ambea AB (publ) (STO:AMBEA)?
Nov 03Is Ambea (STO:AMBEA) A Risky Investment?
Oct 06Estimating The Fair Value Of Ambea AB (publ) (STO:AMBEA)
Aug 10Here's Why Ambea (STO:AMBEA) Has A Meaningful Debt Burden
Apr 05Ambea (STO:AMBEA) Is Increasing Its Dividend To SEK1.25
Apr 05What Is Ambea AB (publ)'s (STO:AMBEA) Share Price Doing?
Oct 07Here's Why Ambea (STO:AMBEA) Has A Meaningful Debt Burden
Jun 29Ambea (STO:AMBEA) Has Announced A Dividend Of kr1.15
Apr 28Ambea (STO:AMBEA) Has Announced A Dividend Of kr1.15
Apr 12Ambea (STO:AMBEA) Has Announced A Dividend Of kr1.15
Mar 29Ambea (STO:AMBEA) Will Pay A Dividend Of kr1.15
Feb 26Ambea (STO:AMBEA) Has Re-Affirmed Its Dividend Of kr1.15
Feb 12Is Ambea AB (publ) (STO:AMBEA) Potentially Undervalued?
Nov 22Opbrengsten en kosten
Hoe Ambea geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 13,769 | 545 | 1,386 | 0 |
| 31 Mar 24 | 13,561 | 496 | 1,427 | 0 |
| 31 Dec 23 | 13,312 | 455 | 1,434 | 0 |
| 30 Sep 23 | 13,126 | 344 | 1,460 | 0 |
| 30 Jun 23 | 12,958 | 330 | 1,498 | 0 |
| 31 Mar 23 | 12,790 | 370 | 1,477 | 0 |
| 31 Dec 22 | 12,635 | 366 | 1,474 | 0 |
| 30 Sep 22 | 12,398 | 308 | 1,378 | 0 |
| 30 Jun 22 | 12,123 | 306 | 1,353 | 0 |
| 31 Mar 22 | 11,831 | 257 | 1,308 | 0 |
| 31 Dec 21 | 11,478 | 237 | 1,260 | 0 |
| 30 Sep 21 | 11,254 | 366 | 1,265 | 0 |
| 30 Jun 21 | 11,074 | 328 | 1,204 | 0 |
| 31 Mar 21 | 10,999 | 343 | 1,216 | 0 |
| 31 Dec 20 | 11,083 | 359 | 1,228 | 0 |
| 30 Sep 20 | 11,122 | 302 | 1,298 | 0 |
| 30 Jun 20 | 11,234 | 307 | 1,364 | 0 |
| 31 Mar 20 | 11,335 | 268 | 1,424 | 0 |
| 31 Dec 19 | 11,040 | 215 | 1,451 | 0 |
| 30 Sep 19 | 9,787 | 211 | 1,384 | 0 |
| 30 Jun 19 | 8,484 | 182 | 1,336 | 0 |
| 31 Mar 19 | 7,125 | 244 | 1,263 | 0 |
| 31 Dec 18 | 6,076 | 295 | 1,218 | 0 |
| 30 Sep 18 | 5,990 | 317 | 1,224 | 0 |
| 30 Jun 18 | 5,937 | 307 | 1,206 | 0 |
| 31 Mar 18 | 5,860 | 253 | 1,140 | 0 |
| 31 Dec 17 | 5,816 | 226 | 1,137 | 0 |
| 30 Sep 17 | 5,763 | 178 | 1,151 | 0 |
| 30 Jun 17 | 5,651 | 148 | 1,122 | 0 |
| 31 Mar 17 | 5,561 | 139 | 1,108 | 0 |
| 31 Dec 16 | 5,335 | 128 | 1,008 | 0 |
| 31 Dec 15 | 4,350 | 3 | 698 | 0 |
| 31 Dec 14 | 4,165 | 46 | 656 | 0 |
Kwaliteitswinsten: AMBEA has high quality earnings.
Groeiende winstmarge: AMBEA's current net profit margins (4%) are higher than last year (2.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: AMBEA's earnings have grown by 14.1% per year over the past 5 years.
Versnelling van de groei: AMBEA's earnings growth over the past year (65.2%) exceeds its 5-year average (14.1% per year).
Winst versus industrie: AMBEA earnings growth over the past year (65.2%) exceeded the Healthcare industry 16.3%.
Rendement op eigen vermogen
Hoge ROE: AMBEA's Return on Equity (11.6%) is considered low.